PNC Financial Services Group
CAI

PNC Financial Services Group’s Caris Life Sciences CAI Stock Holding History

PNC Financial Services Group’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38K Buy
2,131
+487
+30% +$8.72K ﹤0.01% 3494
2026
Q1 		$29.4K Buy
1,644
+1,469
+839% +$32.1K ﹤0.01% 3508
2025
Q4 		$4.72K Sell
175
-680
-80% -$19.2K ﹤0.01% 4259
2025
Q3 		$25.9K Buy
855
+655
+328% +$20.9K ﹤0.01% 3531
2025
Q2 		$5.34K Buy
+200
New +$5.39K ﹤0.01% 4104

Other funds holding CAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

PNC Financial Services Group's CAI Position: Q2 2026 in Review

PNC Financial Services Group increased its Caris Life Sciences (CAI) stake by 30% in Q2 2026, buying an estimated $8.72K and bringing the position to 2,131 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #3494.

PNC Financial Services Group first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. 96 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • PNC Financial Services Group held 2,131 shares of Caris Life Sciences worth $38K as of Q2 2026.
  • PNC Financial Services Group bought 487 Caris Life Sciences shares in Q2 2026, an estimated $8.72K.
  • Caris Life Sciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3494 holding.
  • PNC Financial Services Group first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 96 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.